Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Constellation Brands Inc a un objectif de cours consensus de $185.62, basé sur les évaluations des 21 analystes. Le plus élevé est de $261 attribué par Exane BNP Paribas le novembre 25, 2024, et le plus bas est de $142 attribué par B of A Securities le septembre 3, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Barclays, JP Morgan et Needham le octobre 9, 2025, octobre 8, 2025 et octobre 8, 2025. Avec un objectif de cours moyen de $160 entre Barclays, JP Morgan et Needham, il y a une variation implicite de 14.49% upside pour Constellation Brands Inc à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/09/2025 | 5.19% | Barclays | $150 → $147 | Maintains | Equal-Weight | |||
10/08/2025 | 9.48% | JP Morgan | $173 → $153 | Maintains | Neutral | |||
10/08/2025 | 28.8% | Needham | $180 → $180 | Reiterates | Buy → Buy | |||
10/07/2025 | 14.49% | Morgan Stanley | $176 → $160 | Maintains | Equal-Weight | |||
10/03/2025 | 25.22% | UBS | $205 → $175 | Maintains | Buy | |||
10/02/2025 | 20.21% | Goldman Sachs | $196 → $168 | Maintains | Buy | |||
09/25/2025 | 10.91% | Wells Fargo | $170 → $155 | Maintains | Overweight | |||
09/23/2025 | 3.76% | Citigroup | $155 → $145 | Maintains | Neutral | |||
09/12/2025 | 7.33% | Barclays | $202 → $150 | Downgrade | Overweight → Equal-Weight | |||
09/04/2025 | 39.53% | Bernstein | $225 → $195 | Maintains | Outperform | |||
09/04/2025 | 10.91% | Citigroup | $174 → $155 | Maintains | Neutral | |||
09/04/2025 | 35.96% | BMO Capital | $215 → $190 | Maintains | Outperform | |||
09/04/2025 | 8.77% | TD Cowen | $180 → $152 | Maintains | Hold | |||
09/03/2025 | 13.06% | Deutsche Bank | $182 → $158 | Maintains | Hold | |||
09/03/2025 | 49.55% | Roth Capital | $239 → $209 | Reiterates | Buy → Buy | |||
09/03/2025 | 25.94% | Morgan Stanley | $195 → $176 | Maintains | Equal-Weight | |||
09/03/2025 | 1.61% | B of A Securities | $150 → $142 | Maintains | Underperform | |||
09/03/2025 | 40.25% | Goldman Sachs | $225 → $196 | Maintains | Buy | |||
09/03/2025 | 28.8% | Needham | $200 → $180 | Maintains | Buy | |||
09/03/2025 | 21.65% | Wells Fargo | $196 → $170 | Maintains | Overweight | |||
09/03/2025 | 28.09% | Jefferies | $205 → $179 | Maintains | Buy | |||
07/07/2025 | 46.69% | Jefferies | $194 → $205 | Upgrade | Hold → Buy | |||
07/03/2025 | 46.69% | UBS | $195 → $205 | Maintains | Buy | |||
07/03/2025 | 24.51% | Citigroup | $170 → $174 | Maintains | Neutral | |||
07/03/2025 | 30.23% | B of A Securities | $180 → $182 | Maintains | Neutral | |||
07/03/2025 | 30.23% | JP Morgan | $170 → $182 | Maintains | Neutral | |||
07/03/2025 | 43.11% | Needham | $195 → $200 | Maintains | Buy | |||
06/26/2025 | 44.54% | Barclays | $207 → $202 | Maintains | Overweight | |||
06/26/2025 | 21.65% | JP Morgan | $194 → $170 | Maintains | Neutral | |||
06/25/2025 | 39.53% | UBS | $205 → $195 | Maintains | Buy | |||
06/25/2025 | 40.25% | Wells Fargo | $210 → $196 | Maintains | Overweight | |||
06/25/2025 | 39.53% | Needham | $215 → $195 | Maintains | Buy | |||
06/18/2025 | 28.8% | B of A Securities | $195 → $180 | Maintains | Neutral | |||
06/18/2025 | 21.65% | Citigroup | $190 → $170 | Maintains | Neutral | |||
04/14/2025 | 66.73% | RBC Capital | $289 → $233 | Maintains | Outperform | |||
04/14/2025 | 48.12% | Barclays | $203 → $207 | Maintains | Overweight | |||
04/11/2025 | 35.96% | Citigroup | $200 → $190 | Maintains | Neutral | |||
04/11/2025 | 61% | Goldman Sachs | $260 → $225 | Maintains | Buy | |||
04/11/2025 | 38.82% | JP Morgan | $203 → $194 | Maintains | Neutral | |||
04/11/2025 | 53.85% | BMO Capital | $260 → $215 | Maintains | Outperform | |||
04/11/2025 | 39.53% | Morgan Stanley | $202 → $195 | Maintains | Equal-Weight | |||
04/11/2025 | 53.85% | Needham | $215 → $215 | Reiterates | Buy → Buy | |||
04/10/2025 | 53.85% | Needham | $215 → $215 | Reiterates | Buy → Buy | |||
04/03/2025 | 83.18% | Roth MKM | $284 → $256 | Maintains | Buy | |||
04/02/2025 | 50.27% | Wells Fargo | $230 → $210 | Maintains | Overweight | |||
03/27/2025 | 45.26% | Barclays | $205 → $203 | Maintains | Overweight | |||
03/27/2025 | 53.85% | Needham | $240 → $215 | Maintains | Buy | |||
03/20/2025 | 43.11% | Citigroup | $260 → $200 | Downgrade | Buy → Neutral | |||
03/13/2025 | 46.69% | Barclays | $214 → $205 | Maintains | Overweight | |||
03/07/2025 | 106.8% | RBC Capital | $293 → $289 | Maintains | Outperform | |||
02/27/2025 | 44.54% | Morgan Stanley | $220 → $202 | Downgrade | Overweight → Equal-Weight | |||
02/03/2025 | 109.66% | RBC Capital | $293 → $293 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 43.11% | Piper Sandler | $245 → $200 | Downgrade | Overweight → Neutral | |||
01/27/2025 | 71.74% | Needham | $240 → $240 | Maintains | Buy | |||
01/14/2025 | 35.96% | Truist Securities | $255 → $190 | Maintains | Hold | |||
01/14/2025 | 53.13% | Barclays | $282 → $214 | Maintains | Overweight | |||
01/13/2025 | 109.66% | RBC Capital | $308 → $293 | Maintains | Outperform | |||
01/13/2025 | 78.89% | Evercore ISI Group | $300 → $250 | Maintains | Outperform | |||
01/13/2025 | 75.31% | Piper Sandler | $300 → $245 | Maintains | Overweight | |||
01/13/2025 | 57.42% | Morgan Stanley | $280 → $220 | Maintains | Overweight | |||
01/13/2025 | 71.74% | Needham | $280 → $240 | Reiterates | Buy → Buy | |||
01/13/2025 | 45.26% | JP Morgan | $262 → $203 | Downgrade | Overweight → Neutral | |||
01/13/2025 | 43.83% | Jefferies | $310 → $201 | Downgrade | Buy → Hold | |||
01/10/2025 | 100.36% | Needham | $280 → $280 | Reiterates | Buy → Buy | |||
01/08/2025 | 86.05% | TD Cowen | $270 → $260 | Maintains | Hold | |||
01/08/2025 | 101.79% | Barclays | $300 → $282 | Maintains | Overweight | |||
01/07/2025 | 87.48% | JP Morgan | $293 → $262 | Maintains | Overweight | |||
01/07/2025 | 120.39% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
01/07/2025 | 96.78% | Wells Fargo | $295 → $275 | Maintains | Overweight | |||
12/20/2024 | 100.36% | Needham | $280 → $280 | Reiterates | Buy → Buy | |||
12/06/2024 | 100.36% | Needham | → $280 | Initiates | → Buy | |||
11/26/2024 | 111.09% | Wells Fargo | $300 → $295 | Maintains | Overweight | |||
11/25/2024 | 86.76% | Exane BNP Paribas | → $261 | Initiates | → Neutral | |||
11/19/2024 | 120.39% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
10/15/2024 | 118.25% | BMO Capital | $315 → $305 | Maintains | Outperform | |||
10/08/2024 | 93.2% | TD Cowen | $300 → $270 | Downgrade | Buy → Hold | |||
10/07/2024 | 114.67% | Barclays | $309 → $300 | Maintains | Overweight | |||
10/07/2024 | 82.47% | B of A Securities | $300 → $255 | Downgrade | Buy → Neutral | |||
10/04/2024 | 109.66% | JP Morgan | $307 → $293 | Maintains | Overweight | |||
10/04/2024 | 82.47% | Truist Securities | $265 → $255 | Maintains | Hold | |||
10/04/2024 | 113.24% | Roth MKM | $298 → $298 | Reiterates | Buy → Buy | |||
10/04/2024 | 114.67% | Evercore ISI Group | $310 → $300 | Maintains | Outperform | |||
10/04/2024 | 120.39% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
09/24/2024 | 121.11% | Barclays | $295 → $309 | Maintains | Overweight | |||
09/17/2024 | 120.39% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
09/09/2024 | 111.09% | UBS | $320 → $295 | Maintains | Buy | |||
09/04/2024 | 121.82% | Jefferies | $311 → $310 | Maintains | Buy | |||
09/04/2024 | 113.24% | Roth MKM | $303 → $298 | Maintains | Buy | |||
09/03/2024 | 119.68% | JP Morgan | $320 → $307 | Maintains | Overweight | |||
09/03/2024 | 120.39% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
08/26/2024 | 100.36% | Morgan Stanley | $305 → $280 | Maintains | Overweight | |||
07/31/2024 | 120.39% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
07/19/2024 | 111.09% | Barclays | $287 → $295 | Maintains | Overweight | |||
07/05/2024 | 128.98% | UBS | $315 → $320 | Maintains | Buy | |||
07/05/2024 | 122.54% | Jefferies | $310 → $311 | Maintains | Buy | |||
07/05/2024 | 128.98% | JP Morgan | $291 → $320 | Maintains | Overweight | |||
07/05/2024 | 116.82% | Roth MKM | $305 → $303 | Maintains | Buy | |||
07/05/2024 | 125.4% | BMO Capital | $315 → $315 | Maintains | Outperform | |||
07/03/2024 | 89.62% | Truist Securities | $265 → $265 | Maintains | Hold | |||
06/20/2024 | 125.4% | UBS | $320 → $315 | Maintains | Buy |
Le dernier objectif de prix pour Constellation Brands (NYSE:STZ) a été rapporté par Barclays le octobre 9, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $147.00 s'attendant à ce que STZ se rise dans les 12 prochains mois (un possible changement de 5.19% upside). 74 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Constellation Brands (NYSE:STZ) a été fournie par Barclays, et Constellation Brands maintenu leur note equal-weight.
La dernière amélioration pour Constellation Brands Inc a eu lieu le juillet 7, 2025 lorsque Jefferies a augmenté leur objectif de prix à $205. Jefferies avait précédemment a hold pour Constellation Brands Inc.
La dernière réduction pour Constellation Brands Inc a eu lieu le septembre 12, 2025 lorsque Barclays a changé leur objectif de prix de $202 à $150 pour Constellation Brands Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Constellation Brands, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Constellation Brands a été déposée le octobre 9, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 9, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Constellation Brands (STZ) était un maintenu avec un objectif de prix de $150.00 à $147.00. Le prix actuel de Constellation Brands (STZ) est de $139.75, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.